Flow Traders U.S.’s iShares Health Innovation Active ETF BMED Stock Holding History
Bought
Maintained
Sold
Other funds holding BMED
Flow Traders U.S.'s BMED Position: Q2 2022 in Review
Flow Traders U.S. sold out of iShares Health Innovation Active ETF (BMED) in Q2 2022, closing a stake of 30,063 shares — an estimated $763K sold.
Flow Traders U.S. first reported a position in BMED in Q1 2022 and held it in 1 quarter. The position peaked at $763K in Q1 2022. 4 funds tracked by Wall St. Rank hold BMED as of Q2 2022.
- Flow Traders U.S. reported no remaining iShares Health Innovation Active ETF position as of Q2 2022 after selling out during the quarter.
- Flow Traders U.S. sold 30,063 iShares Health Innovation Active ETF shares in Q2 2022, an estimated $763K.
- Flow Traders U.S. first reported a position in iShares Health Innovation Active ETF in Q1 2022 and held it in 1 quarter.
- Flow Traders U.S.'s iShares Health Innovation Active ETF position peaked at $763K in Q1 2022.
- 4 funds tracked by Wall St. Rank held iShares Health Innovation Active ETF as of Q2 2022.
Based on Flow Traders U.S.'s 13F filing for Q2 2022, filed 12 Aug 2022.